These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 29017565)

  • 1. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
    Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
    Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
    Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
    Trials; 2013 May; 14():138. PubMed ID: 23672353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
    Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
    Trials; 2015 May; 16():222. PubMed ID: 25994188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial.
    Du K; Liu J; Tan N; Huang X; Wang J; Zhao H; Wang W
    Front Pharmacol; 2022; 13():1017734. PubMed ID: 36618925
    [No Abstract]   [Full Text] [Related]  

  • 5. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
    Guo L; Yuan H; Zhang D; Zhang J; Hua Q; Ma X; Chen K
    Medicine (Baltimore); 2020 May; 99(21):e20271. PubMed ID: 32481305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
    Li X; Zhang J; Huang J; Ma A; Yang J; Li W; Wu Z; Yao C; Zhang Y; Yao W; Zhang B; Gao R;
    J Am Coll Cardiol; 2013 Sep; 62(12):1065-1072. PubMed ID: 23747768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
    Wang X; Zhao Z; Hou Y; Tang E; Zhao G; Wang S; Bi Y; Zhong C; Ren M; Zhang J; Mao J; Zhang B
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):295-300. PubMed ID: 29713851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Qishen granules for chronic heart failure: A protocol for systematic review and meta-analysis.
    Liu J; Xu Z; Yang S; Du K; Zhang Y; Tan N; Sun X; Zhao H; Wang W
    Medicine (Baltimore); 2020 Dec; 99(52):e23901. PubMed ID: 33350788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial.
    Kim KH; Kim HK; Hwang IC; Lee SP; Cho HJ; Kang HJ; Kim YJ; Sohn DW
    Trials; 2013 Jun; 14():188. PubMed ID: 23799908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Qishen Yiqi Drop Pill for Chronic Heart Failure: An Updated Meta-Analysis of 85 Studies.
    Wang H; Li L; Qing X; Zhang S; Li S
    Cardiovasc Ther; 2020; 2020():8138764. PubMed ID: 33042225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qishen Taohong Granule () as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure: A Randomized Controlled Trial.
    Li XX; Wu Y; Fan ZJ; Cui J; Li D; Lin Q; Zhuang R; Yan RK; Lin Q; Li Y
    Chin J Integr Med; 2022 Jan; 28(1):12-19. PubMed ID: 34387827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial.
    Wang X; Hu D; Dang S; Huang H; Huang CX; Yuan MJ; Tang YH; Zheng QS; Yin F; Zhang S; Zhang BL; Gao RL;
    Chin Med J (Engl); 2017 Jul; 130(14):1639-1647. PubMed ID: 28685712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial.
    van Riet EE; Hoes AW; Limburg A; van der Hoeven H; Landman MA; Rutten FH
    BMC Cardiovasc Disord; 2014 Jan; 14():1. PubMed ID: 24400643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy and Safety of Xinmailong Injection in Patients with Chronic Heart Failure: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Xue J; Xu Y; Deng Y; Li F; Liu F; Liu L; Wang X; Wang J; Wang X
    J Altern Complement Med; 2019 Aug; 25(8):856-860. PubMed ID: 31295009
    [No Abstract]   [Full Text] [Related]  

  • 16. Vericiguat on C-reactive Protein Level and Prognosis in Patients with Hypertensive Heart Failure.
    Cao Y; Sun Y; Miao B; Zhang X; Zhao Q; Qi L; Chen Y; Zhu L
    High Blood Press Cardiovasc Prev; 2024 Sep; 31(5):485-492. PubMed ID: 39168957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial.
    Cheang I; Yao W; Zhou Y; Zhu X; Ni G; Lu X; Liao S; Gao R; Zhou F; Shen J; Leung AYL; Jiang M; Kong H; Bai L; Mahemuti A; Yuan H; Dong YG; Wong CK; Xu Q; Zhang G; Wu J; Lu Q; Zhang J; Cha C; Ren Q; Fu L; Wang B; Xu Y; Hu H; Dong J; Shang Z; Yu C; Li S; Yao C; Gao L; Zhang H; Rosenzweig A; Jia Z; Li X;
    Nat Med; 2024 Aug; 30(8):2295-2302. PubMed ID: 39095596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure.
    Xian S; Yang Z; Lee J; Jiang Z; Ye X; Luo L; Jin L; Yang T; Ye S; Lu D
    J Ethnopharmacol; 2016 Jun; 186():136-142. PubMed ID: 27045864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study.
    Navarro-Peñalver M; Perez-Martinez MT; Gómez-Bueno M; García-Pavía P; Lupón-Rosés J; Roig-Minguell E; Comin-Colet J; Bayes-Genis A; Noguera JA; Pascual-Figal DA
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):543-550. PubMed ID: 29929385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF).
    Zhang X; Wang WY; Zhang K; Tian J; Zheng JL; Chen J; An SM; Wang SY; Liu YP; Zhao Y; Wang JJ; Yang M; Tang YD
    Trials; 2019 Feb; 20(1):143. PubMed ID: 30782213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.